Literature DB >> 20733131

Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.

Akke Botma1, Fokko M Nagengast, Marieke G M Braem, Jan C M Hendriks, Jan H Kleibeuker, Hans F A Vasen, Ellen Kampman.   

Abstract

PURPOSE: High body mass index (BMI) is an established risk factor for sporadic colorectal cancer. Still, the influence of BMI on hereditary colorectal cancer (eg, Lynch syndrome [LS]), is unknown. The objective of this study was to assess whether BMI is associated with colorectal adenoma occurrence in persons with LS. PATIENTS AND METHODS: A prospective cohort study of 486 patients with LS was conducted. Cox regression models with robust sandwich estimates controlling for age, sex, extent of colon surgery, smoking, and alcohol intake were used to evaluate associations between BMI, height, weight, weight change, and risk of colorectal adenomas. Analyses were performed separately for those without (incident cohort; n = 243) and those with (prevalent cohort; n = 243) a history of colorectal cancer neoplasms at baseline.
RESULTS: A statistically significant association between current overweight (≥ 25 kg/m(2)) and developing colorectal adenomas was seen among men in the incident cohort (overweight v normal weight hazard ratio [HR], 8.72; 95% CI, 2.06 to 36.96). This association was not observed among women (overweight v normal weight HR, 0.75; 95% CI, 0.19 to 3.07), nor was it observed in the prevalent cohort. In the incident cohort, height was statistically significantly associated with a decreased risk of adenomatous polyps among men (per 5 cm HR, 0.43; 95% CI, 0.23 to 0.83), but the association between weight and adenomatous polyps among men was of marginal significance (per 5 kg HR, 1.17; 95% CI, 1.00 to 1.37). No statistically significant associations were observed among women in either the incident cohort or the prevalent cohort.
CONCLUSION: Excess body weight increased the risk of incident colorectal adenomas in people with LS. This increased risk was seen only in men.

Entities:  

Mesh:

Year:  2010        PMID: 20733131     DOI: 10.1200/JCO.2010.28.0453

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

1.  Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review.

Authors:  Adriana M Coletta; Susan K Peterson; Leticia A Gatus; Kate J Krause; Susan M Schembre; Susan C Gilchrist; Mala Pande; Eduardo Vilar; Y Nancy You; Miguel A Rodriguez-Bigas; Larkin L Strong; Patrick M Lynch; Karen H Lu; Karen Basen-Engquist
Journal:  Fam Cancer       Date:  2019-06-24       Impact factor: 2.375

Review 2.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 3.  Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?

Authors:  Fränzel J B van Duijnhoven; Akke Botma; Renate Winkels; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  Phytochemicals and colorectal cancer prevention--myth or reality?

Authors:  Luigi Ricciardiello; Franco Bazzoli; Vincenzo Fogliano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-06       Impact factor: 46.802

Review 5.  Colorectal Cancer in Young Adults.

Authors:  Anand Venugopal; Elena M Stoffel
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

6.  Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer.

Authors:  Elizabeth D Kantor; Johanna W Lampe; Ulrike Peters; Thomas L Vaughan; Emily White
Journal:  Nutr Cancer       Date:  2013-09-20       Impact factor: 2.900

7.  Associations of Height With the Risks of Colorectal and Endometrial Cancer in Persons With Lynch Syndrome.

Authors:  Jesca G M Brouwer; Polly A Newcomb; Tanya M Bisseling; Jane C Figueiredo; John L Hopper; Mark A Jenkins; Jan J Koornstra; Noralane M Lindor; Hans F A Vasen; Aung K Win; Ellen Kampman; Fränzel J B van Duijnhoven
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

8.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

Review 9.  Lynch syndrome: the patients' perspective.

Authors:  Jurgen Seppen; Linda Bruzzone
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.